GGrantIndex
Sort

10,829 grants matching car t

OLIGOSACCHORIDE TECHNOLOGY TO PREVENT SKIN CANCER

$373,019
Pangea Phytoceuticals · R44 · FY2000 · CA

MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy

$372,867
Adam M Sonabend · Northwestern University At Chicago · R01 · FY2021 · NS

Imaging T-cell Activation and Co-stimulation in Prostate Cancer Immunotherapy

$372,861
Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA

Expert Memory: Superior Encoding, Enhanced Retrieval, and Refined Perception

$372,704
Timothy E Curran · University Of Colorado · R01 · FY2014 · MH

RI: Medium: Collaborative Research: Novel microLIDAR Design and Sensing Algorithms for Flapping-Wing Micro-Aerial Vehicles

$372,655
Karthik Dantu · Suny At Buffalo · · FY2015 · CSE

ROLE OF THE G-CSF RECEPTOR IN PROGENITOR MOBILIZATION

$372,400
Daniel C Link · Washington University · R01 · FY2014 · HL

PS11-1114, Community Approaches to Reducing STDs (CARS)

$372,396
Peter R Kerndt · University Of Southern California · U22 · FY2013 · PS

Preventing Alcohol Misuse among Young Adult Veterans through Brief Online Intervention

$372,396
Eric R. Pedersen · University Of Southern California · R01 · FY2022 · AA

Growth Proteins and Synaptic Plasticity

$372,366
Aryeh Routtenberg · Northwestern University · · FY2001 · BIO

II-EN: Shared Virtual Environments for Studying Social Influences on Risky Cycling and Pedestrian Behavior

$372,337
Joseph K Kearney · University Of Iowa · · FY2013 · CSE

Quantifying the attentional template

$372,165
Joy Jia Geng · University Of California At Davis · R01 · FY2022 · MH

Regulation of Hepatic P450s by Anti-Cholesterol Drugs

$372,149
Thomas A Kocarek · Wayne State University · R01 · FY2014 · HL

Optimizing risk messages to promote waterpipe tobacco cessation in young adults

$372,066
Darren M Mays · Georgetown University · R01 · FY2017 · CA

OLIGOSACCHORIDE TECHNOLOGY TO PREVENT SKIN CANCER

$371,934
Pangea Phytoceuticals · R44 · FY2001 · CA

Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers

$371,925
Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA

Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers

$371,925
Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA

Measuring Human Exposure to PBDEs

$371,868
Thomas F Webster · Boston University Medical Campus · R01 · FY2008 · ES

CERVICAL SPINE INJURIES IN FRONT, REAR AND SIDE IMPACTS

$371,850
Yale University · R01 · FY2000 · AR

The transcriptional basis of tumor promotion

$371,814
Joseph Locker Locker · Albert Einstein College Of Medicine · R01 · FY2010 · CA

Off-The-Shelf Dual Targeted NK Cells For NHL

$371,747
Daniel J Weisdorf · University Of Minnesota · P01 · FY2022 · CA

Adhesion Molecules of the Intercalated Disc in Cardiomyopathy

$371,728
Kirk U Knowlton · University Of California, San Diego · P01 · FY2008 · HL

Measuring Human Exposure to PBDEs

$371,436
Thomas F Webster · Boston University Medical Campus · R01 · FY2009 · ES

GOALI: Novel Integration of AC/DC Charger and DC/DC Converter for Plug-in Hybrid Electric Vehicles

$371,350
Alireza Khaligh · Illinois Institute Of Technology · · FY2008 · ENG

MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy

$371,300
Adam M Sonabend · Northwestern University At Chicago · R01 · FY2020 · NS

Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia

$371,250
Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2022 · CA